Clean Science & Technology Ltd

Clean Science Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Clean Science & Technology Ltd

₹ 764 -0.83%
13 Jul 11:02 a.m.
cleanscience.co.in BSE: 543318 NSE: CLEAN
About

Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]

Key Points

Product Segments (FY26):[1][2]
a) Performance Chemicals (72%):
The company manufactures Monomethyl Ether of Hydroquinone (MEHQ), which is used as a polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads), Butylated Hydroxy Anisole (BHA), used as anti-oxidant in food and feed industry, Ascorbyl Palmitate (AP), used in infant food formulations, breakfast cereals, and cosmetics, Tertiary Butyl Hydroquinone (TBHQ) used as a stabilizer in the oil industry and Hindered Amine light Stabilizers (HALS), used in water treatment and UV stabilization in a variety of polymers. TBHQ ranks 2nd globally, while the rest of the products are ranked no.1.
b) Pharma & Agro Intermediates (19%):
It manufactures Guaiacol (ranked 2nd globally & 1st in India), a precursor to manufacture APIs for cough syrup and key raw material to produce Vanillin, Dicyclohexyl Carbodiimide (ranked 2nd globally & 1st in India), used as a reagent in anti-retroviral, Veratrole (amongst largest in India), an intermediate in agrochemical industry and DHDT (No 1 in India), used as a reagent in anti-retroviral.
c) FMCG Chemicals (9%):
It manufactures 4-Methoxy Acetophenone (4-MAP) (No 1 globally), used in UV blockers in sunscreens, and Anisole (No 1 globally), used as a precursor to perfumes, insect pheromones, and pharmaceuticals. The majority of Anisole produced is used for captive consumption.

Website BSE NSE
  • Market Cap ₹ 8,116 Cr.
  • Current Price ₹ 764
  • High / Low ₹ 1,490 / 652
  • Stock P/E 32.3
  • Book Value ₹ 155
  • Dividend Yield 0.79 %
  • ROCE 21.6 %
  • ROE 16.2 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 20.1%

Cons

  • The company has delivered a poor sales growth of 9.73% over past five years.
  • Promoter holding has decreased over last 3 years: -27.2%
  • Working capital days have increased from 127 days to 225 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE 500 Nifty 500 BSE Commodities BSE 250 SmallCap Index BSE 400 MidSmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
217 188 181 195 225 217 228 232 245 220 213 185 197
112 112 106 108 127 120 133 129 141 119 121 113 109
Operating Profit 105 77 76 86 99 98 95 102 105 101 92 72 88
OPM % 49% 41% 42% 44% 44% 45% 41% 44% 43% 46% 43% 39% 45%
12 12 5 8 13 10 10 5 12 13 6 9 0
Interest 0 0 0 0 1 0 0 0 0 0 0 0 0
Depreciation 10 11 11 11 11 11 11 11 11 11 11 11 11
Profit before tax 108 78 69 83 101 96 94 96 105 102 86 70 77
Tax % 25% 25% 25% 25% 26% 25% 28% 22% 25% 25% 25% 26% 25%
81 59 52 62 75 72 67 74 79 77 65 52 58
EPS in Rs 7.62 5.51 4.89 5.87 7.04 6.79 6.35 6.97 7.40 7.21 6.08 4.88 5.47
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
164 140 191 241 393 419 512 685 936 789 922 815
106 92 118 168 256 234 253 385 533 452 523 463
Operating Profit 58 48 72 73 137 186 260 300 403 338 400 353
OPM % 35% 34% 38% 30% 35% 44% 51% 44% 43% 43% 43% 43%
3 2 4 5 11 11 25 30 39 38 36 28
Interest 3 3 0 1 0 0 0 0 1 1 1 0
Depreciation 5 6 6 8 11 14 17 25 36 44 44 44
Profit before tax 53 41 70 70 137 182 267 305 405 331 391 336
Tax % 34% 34% 33% 30% 28% 23% 26% 25% 25% 25% 25% 25%
35 27 47 49 98 140 198 229 304 248 292 251
EPS in Rs 247.58 192.41 330.79 343.72 690.82 1,051.82 18.68 21.52 28.57 23.31 27.51 23.64
Dividend Payout % 10% 13% 12% 12% 15% 2% 134% 15% 18% 21% 22% 17%
Compounded Sales Growth
10 Years: 19%
5 Years: 10%
3 Years: -4%
TTM: -12%
Compounded Profit Growth
10 Years: 25%
5 Years: 5%
3 Years: -6%
TTM: -14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -16%
1 Year: -46%
Return on Equity
10 Years: 27%
5 Years: 24%
3 Years: 20%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 1 1 1 1 1 1 11 11 11 11 11 11
Reserves 76 99 143 186 271 341 529 758 1,008 1,205 1,446 1,635
20 12 0 1 3 3 0 0 1 1 1 1
29 27 35 48 53 85 120 156 139 154 147 137
Total Liabilities 127 139 179 236 328 430 660 925 1,159 1,371 1,605 1,784
60 64 77 101 126 166 186 296 427 401 364 340
CWIP 0 0 2 1 4 3 55 44 4 2 4 4
Investments 1 1 32 18 76 134 233 247 428 666 907 1,155
65 75 68 115 122 127 187 338 300 302 330 285
Total Assets 127 139 179 236 328 430 660 925 1,159 1,371 1,605 1,784

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
69 45 85 160 193 127 299 277 279 310
-52 -17 -94 -106 -186 -124 -245 -228 -221 -244
-15 -5 -11 -55 -6 -0 -55 -53 -52 -64
Net Cash Flow 2 23 -20 -1 1 4 -0 -3 6 3
Free Cash Flow -33 13 46 109 109 -2 164 264 270 289
CFO/OP 124% 91% 88% 109% 100% 65% 98% 105% 94% 114%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 36 68 41 60 55 61 53 82 58 75 73 67
Inventory Days 202 246 165 93 79 98 156 143 122 146 118 137
Days Payable 71 79 73 85 48 101 180 166 90 121 83 100
Cash Conversion Cycle 166 235 134 69 87 58 29 59 89 100 108 104
Working Capital Days 87 131 64 61 62 33 32 90 66 78 79 225
ROCE % 42% 55% 42% 59% 59% 61% 47% 45% 29% 29% 22%

Insights

In beta
Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
India Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Performance Chemicals Segment Share
%
R&D Scientists Count
Count
Number of Customers
Count
Number of Manufacturing Units
Count
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

14 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.98% 74.98% 74.98% 74.98% 74.98% 74.97% 74.97% 74.96% 74.96% 50.96% 50.96% 51.29%
5.84% 6.01% 5.92% 5.88% 6.05% 5.83% 5.98% 6.07% 6.21% 11.14% 10.01% 13.38%
6.41% 5.23% 5.13% 5.04% 4.55% 4.77% 5.46% 5.77% 5.92% 18.97% 19.76% 17.14%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01%
12.78% 13.79% 13.98% 14.11% 14.42% 14.43% 13.59% 13.21% 12.91% 18.91% 19.26% 18.17%
No. of Shareholders 2,66,9712,85,2592,78,6532,79,3952,73,8412,54,6292,46,7982,37,0162,25,4842,39,9742,43,6062,37,113

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls